BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Haisco Pharmaceutical Group readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of studies Haisco Pharmaceutical Group's dru
 gs run\, from ClinicalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07158268-64@assetmemo.bio
DTSTAMP:20261121T010439Z
DTSTART;VALUE=DATE:20261220
DTEND;VALUE=DATE:20261221
SUMMARY:HSK47388: Phase 2 readout est. (NCT07158268)
DESCRIPTION:HSK47388\, phase 2\, Psoriasis.\nStudy: A Phase 2 Study of HSK4
 7388 Tablets to Evaluate the Efficacy and Safety in Patients With Moderate
 -to-Severe Plaque Psoriasis\nEstimated primary completion: 20 December 202
 6. This is a ClinicalTrials.gov estimate\, not a confirmed readout date\, 
 and it can move.\nDrug page: https://assetmemo.bio/drug/hsk47388#upcoming-
 events\nRegistry record: https://clinicaltrials.gov/study/NCT07158268
URL:https://assetmemo.bio/drug/hsk47388#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07623486-1385@assetmemo.bio
DTSTAMP:20261121T010439Z
DTSTART;VALUE=DATE:20270331
DTEND;VALUE=DATE:20270401
SUMMARY:HSK44459: Phase 1/2 readout est. (NCT07623486)
DESCRIPTION:HSK44459\, phase 1/2\, Psoriasis.\nStudy: Trial of HSK44459 Cre
 am for the Management Plaque Psoriasis\nEstimated primary completion: Marc
 h 2027. This is a ClinicalTrials.gov estimate\, not a confirmed readout da
 te\, and it can move.\nDrug page: https://assetmemo.bio/drug/hsk44459#upco
 ming-events\nRegistry record: https://clinicaltrials.gov/study/NCT07623486
URL:https://assetmemo.bio/drug/hsk44459#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07658339-1539@assetmemo.bio
DTSTAMP:20261121T010439Z
DTSTART;VALUE=DATE:20270611
DTEND;VALUE=DATE:20270612
SUMMARY:HSK39004: Phase 3 readout est. (NCT07658339)
DESCRIPTION:HSK39004\, phase 3\, Chronic Obstructive Pulmonary Disease.\nSt
 udy: A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of HSK39
 004 Inhalation Suspension in Patients With COPD\nEstimated primary complet
 ion: 11 June 2027. This is a ClinicalTrials.gov estimate\, not a confirmed
  readout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/hs
 k39004#upcoming-events\nRegistry record: https://clinicaltrials.gov/study/
 NCT07658339
URL:https://assetmemo.bio/drug/hsk39004#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07070739-1385@assetmemo.bio
DTSTAMP:20261121T010439Z
DTSTART;VALUE=DATE:20270731
DTEND;VALUE=DATE:20270801
SUMMARY:HSK44459: Phase 2 readout est. (NCT07070739)
DESCRIPTION:HSK44459\, phase 2.\nStudy: A Long-term Study of HSK44459 Table
 ts in Participants With Bechet's Disease\nEstimated primary completion: Ju
 ly 2027. This is a ClinicalTrials.gov estimate\, not a confirmed readout d
 ate\, and it can move.\nDrug page: https://assetmemo.bio/drug/hsk44459#upc
 oming-events\nRegistry record: https://clinicaltrials.gov/study/NCT0707073
 9
URL:https://assetmemo.bio/drug/hsk44459#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07425210-1539@assetmemo.bio
DTSTAMP:20261121T010439Z
DTSTART;VALUE=DATE:20270731
DTEND;VALUE=DATE:20270801
SUMMARY:HSK39004: Phase 2 readout est. (NCT07425210)
DESCRIPTION:HSK39004\, phase 2\, Chronic Obstructive Pulmonary Disease.\nSt
 udy: Long-Term Safety and Efficacy of HSK39004 Dry Powder Inhaler in COPD\
 nEstimated primary completion: July 2027. This is a ClinicalTrials.gov est
 imate\, not a confirmed readout date\, and it can move.\nDrug page: https:
 //assetmemo.bio/drug/hsk39004#upcoming-events\nRegistry record: https://cl
 inicaltrials.gov/study/NCT07425210
URL:https://assetmemo.bio/drug/hsk39004#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT06422117-8791@assetmemo.bio
DTSTAMP:20261121T010439Z
DTSTART;VALUE=DATE:20270730
DTEND;VALUE=DATE:20270731
SUMMARY:Crisugabalin: Phase 3 readout est. (NCT06422117)
DESCRIPTION:Crisugabalin\, phase 3.\nStudy: Efficacy and Safety of HSK16149
  Capsule in the Treatment of Moderate and Severe Central Neuropathic Pain 
 in China\nEstimated primary completion: 30 July 2027. This is a ClinicalTr
 ials.gov estimate\, not a confirmed readout date\, and it can move.\nDrug 
 page: https://assetmemo.bio/drug/crisugabalin#upcoming-events\nRegistry re
 cord: https://clinicaltrials.gov/study/NCT06422117
URL:https://assetmemo.bio/drug/crisugabalin#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07583849-1539@assetmemo.bio
DTSTAMP:20261121T010439Z
DTSTART;VALUE=DATE:20270930
DTEND;VALUE=DATE:20271001
SUMMARY:HSK39004: Phase 3 readout est. (NCT07583849)
DESCRIPTION:HSK39004\, phase 3\, Chronic Obstructive Pulmonary Disease.\nSt
 udy: A Multicenter\, Randomized\, Double-blind\, Placebo-controlled\, Para
 llel-group Phase III Study of HSK39004 Inhalation Powder for the Treatment
  of COPD\nEstimated primary completion: 30 September 2027. This is a Clini
 calTrials.gov estimate\, not a confirmed readout date\, and it can move.\n
 Drug page: https://assetmemo.bio/drug/hsk39004#upcoming-events\nRegistry r
 ecord: https://clinicaltrials.gov/study/NCT07583849
URL:https://assetmemo.bio/drug/hsk39004#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07335055-64@assetmemo.bio
DTSTAMP:20261121T010439Z
DTSTART;VALUE=DATE:20271015
DTEND;VALUE=DATE:20271016
SUMMARY:HSK47388: Phase 2 readout est. (NCT07335055)
DESCRIPTION:HSK47388\, phase 2\, Ulcerative Colitis.\nStudy: A Study for HS
 K47388 in Participants With Ulcerative Colitis\nEstimated primary completi
 on: 15 October 2027. This is a ClinicalTrials.gov estimate\, not a confirm
 ed readout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/
 hsk47388#upcoming-events\nRegistry record: https://clinicaltrials.gov/stud
 y/NCT07335055
URL:https://assetmemo.bio/drug/hsk47388#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07634367-1539@assetmemo.bio
DTSTAMP:20261121T010439Z
DTSTART;VALUE=DATE:20271224
DTEND;VALUE=DATE:20271225
SUMMARY:HSK39004: Phase 3 readout est. (NCT07634367)
DESCRIPTION:HSK39004\, phase 3\, Chronic Obstructive Pulmonary Disease.\nSt
 udy: Long-Term Safety and Efficacy of HSK39004 Inhalation Suspension in CO
 PD\nEstimated primary completion: 24 December 2027. This is a ClinicalTria
 ls.gov estimate\, not a confirmed readout date\, and it can move.\nDrug pa
 ge: https://assetmemo.bio/drug/hsk39004#upcoming-events\nRegistry record: 
 https://clinicaltrials.gov/study/NCT07634367
URL:https://assetmemo.bio/drug/hsk39004#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07519070-1385@assetmemo.bio
DTSTAMP:20261121T010439Z
DTSTART;VALUE=DATE:20280405
DTEND;VALUE=DATE:20280406
SUMMARY:HSK44459: Phase 3 readout est. (NCT07519070)
DESCRIPTION:HSK44459\, phase 3\, Idiopathic Pulmonary Fibrosis.\nStudy: A M
 ulticenter\, Randomized\, Double-Blind\, Placebo-Controlled Phase III Stud
 y to Evaluate the Efficacy and Safety of HSK44459 Tablets in Patients With
  Idiopathic Pulmonary Fibrosis\nEstimated primary completion: 5 April 2028
 . This is a ClinicalTrials.gov estimate\, not a confirmed readout date\, a
 nd it can move.\nDrug page: https://assetmemo.bio/drug/hsk44459#upcoming-e
 vents\nRegistry record: https://clinicaltrials.gov/study/NCT07519070
URL:https://assetmemo.bio/drug/hsk44459#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07503587-1385@assetmemo.bio
DTSTAMP:20261121T010439Z
DTSTART;VALUE=DATE:20281230
DTEND;VALUE=DATE:20281231
SUMMARY:HSK44459: Phase 3 readout est. (NCT07503587)
DESCRIPTION:HSK44459\, phase 3.\nStudy: Evaluating the Efficacy and Safety 
 of of HSK44459 in People With Progressive Pulmonary Fibrosis\nEstimated pr
 imary completion: 30 December 2028. This is a ClinicalTrials.gov estimate\
 , not a confirmed readout date\, and it can move.\nDrug page: https://asse
 tmemo.bio/drug/hsk44459#upcoming-events\nRegistry record: https://clinical
 trials.gov/study/NCT07503587
URL:https://assetmemo.bio/drug/hsk44459#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
